It was reported that partial linkage disequilibrium exists between the NAT1*10 allele and the NAT2 fast acetylation genotype, and a reduced risk for bladder cancer was identified in carriers of these co-existing genotypes [34]. This evidence concerns the gene NAT2 and urinary bladder cancer.